<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">Until recently, most of our knowledge on genome diversity and instability in humans has been from population studies. In 1959, aneuploidies were first identified in individuals with developmental syndromes and congenital disorders such as those associated with Klinefelter, Turner and Down syndromes 
 <xref rid="bib2" ref-type="bibr">[2]</xref>, 
 <xref rid="bib3" ref-type="bibr">[3]</xref>, 
 <xref rid="bib4" ref-type="bibr">[4]</xref>, 
 <xref rid="bib5" ref-type="bibr">[5]</xref>, 
 <xref rid="bib6" ref-type="bibr">[6]</xref>. Subsequent studies in fetal losses revealed that human conceptions have exceptionally high levels of aneuploidy, particularly in association with maternal age 
 <xref rid="bib7" ref-type="bibr">[7]</xref>. As a result, countries across the world have implemented prenatal screening programs 
 <xref rid="bib8" ref-type="bibr">[8]</xref>.
</p>
